TKIs and Vascular Adverse Events in Patients With Chronic Myeloid Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tyrosine Kinase Inhibitors and Vascular Adverse Events in Patients with Chronic Myeloid Leukemia: A Population-Based, Propensity Score-Matched Cohort Study
Oncologist 2021 Nov 01;26(11)974-982, MT Chen, ST Huang, CW Lin, BS Ko, WJ Chen, HH Huang, FY HsiaoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.